Alimera Sciences Inc expected to post a loss of 54  cents a share - Earnings Preview

Alimera Sciences

26/04/2021 22:14

* Alimera Sciences Inc  ALIM.OQ   ALIM.O  is expected to show
a fall in quarterly revenue when it reports results on April 28.
* The Alpharetta, Georgia-based company is expected to report  a
16.9% decrease in revenue to $12.07 million from $14.53 million
a year ago, according to the mean estimate from 4 analysts,
based on Refinitiv data.​​
​* Refinitiv's mean analyst estimate for Alimera Sciences Inc is
for a loss of 54 cents per share. For the same quarter last
year, the company reported a loss of 24 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts had risen by
about 56.7% in the last three months.​
* Wall Street's median 12-month price target for Alimera
Sciences Inc is $15.75​, about 32.1% above​ its last closing
price of $10.70. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.04       -0.04      -0.18     Missed  -315.4
 Sep. 30 2020  -0.44       -0.44      -0.12     Beat    72.9
 Jun. 30 2020  -1.09       -1.61      -0.51     Beat    68.4​
 Mar. 31 2020  -0.44       -0.43      -0.24     Beat    44.5
 Dec.          -0.35​      -0.45      0.08      Beat    117.7​
 31​ 2019​                                              
 Sep. 30 2019  -0.57       -0.60      -0.60     Met     0​
 Jun. 30 2019  -0.55       -0.55      -1.05     Missed  -90.9
 Mar. 31 2019  -0.63       -0.63      -0.60     Beat    4.8
 This summary was machine generated April 26 at 21:14 GMT.  All
figures in US dollars unless otherwise stated